Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Watkins

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trialsJanani S Iyer, Harsha Pokkalla, Charles Biddle-Snead, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialMichael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Nature Medicine|August 7, 2024
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseasesJanani S Iyer, Dinkar Juyal, Quang Le, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trialsJanani S Iyer, Harsha Pokkalla, Charles Biddle-Snead, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialMichael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Nature Medicine|August 7, 2024
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseasesJanani S Iyer, Dinkar Juyal, Quang Le, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
Pageof 6